U.S. Market Rallies Led By Strong Gains in Amgen And Boeing Stocks

The Dow Jones Industrial Average logged back-to-back gains over two sessions in early June 2026, driven by outsized moves in a handful of blue-chip names. On June 10, the index closed up 288 points as AMGN and CAT led the advance. Amgen's shares closed at $337.73 that day, lifted in part by Morgan Stanley raising its price target to $340 from $332, reinforcing confidence in the biotech's near-term earnings trajectory.

A separate session recorded a 265-point gain for the Dow, this time paced by AMGN and HON. Honeywell's shares rose roughly 3.0% while Amgen added about 3.8%, together accounting for approximately 117 points of that advance. BA also contributed meaningfully to the broader index move across both sessions, benefiting from improving sentiment around aerospace order flow.

The consecutive rallies reflect selective strength in the Dow's industrial and healthcare components rather than a broad-market surge. CAT's gains align with continued demand signals in construction and heavy equipment, while Amgen's persistent outperformance underscores investor appetite for large-cap biotech names with visible earnings growth. Boeing's contribution, though smaller than the headline movers, carries weight given the stock's historically elevated per-share price and its drag on the index during prior periods of production uncertainty.

Taken together, the sessions point to rotation into blue-chip industrials and healthcare as a source of stability within a market still weighing Federal Reserve rate policy and energy price pressures. The Dow's gains were concentrated rather than uniform, a pattern that often signals sector-specific catalysts rather than a macro-driven risk-on shift.